971681

Louise Taber, MD — FEI 3003141724

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 20, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Phoenix, AZ (United States)

Additional Details

Clinical Investigator (CI)